48 related articles for article (PubMed ID: 10944002)
1. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.
Sharma RK; Candelario-Jalil E; Feineis D; Bringmann G; Fiebich BL; Akundi RS
Neurotox Res; 2017 Nov; 32(4):649-660. PubMed ID: 28721631
[TBL] [Abstract][Full Text] [Related]
2. Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro.
Wang R; Cui Y; Xu Y; Irudayaraj J
PLoS One; 2017; 12(2):e0172243. PubMed ID: 28199384
[TBL] [Abstract][Full Text] [Related]
3. Real-time monitoring of superoxide generation and cytotoxicity in neuroblastoma mitochondria induced by 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.
Boulton SJ; Keane PC; Morris CM; McNeil CJ; Manning P
Redox Rep; 2012; 17(3):108-14. PubMed ID: 22664359
[TBL] [Abstract][Full Text] [Related]
4. Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.
Sontag TA; Lange KW; Heim C; Kolasiewicz W; Tucha O; Sontag KH
J Neural Transm (Vienna); 2009 Oct; 116(10):1267-71. PubMed ID: 19609633
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?
Riederer P; Foley P; Bringmann G; Feineis D; Brückner R; Gerlach M
Eur J Pharmacol; 2002 May; 442(1-2):1-16. PubMed ID: 12020676
[TBL] [Abstract][Full Text] [Related]
6. Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on human serotonergic cells.
Bringmann G; Brückner R; Mössner R; Feineis D; Heils A; Lesch KP
Neurochem Res; 2000 Jun; 25(6):837-43. PubMed ID: 10944002
[TBL] [Abstract][Full Text] [Related]
7. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis.
Bringmann G; Feineis D; God R; Peters K; Peters EM; Scholz J; Riederer F; Moser A
Bioorg Med Chem; 2002 Jul; 10(7):2207-14. PubMed ID: 11983518
[TBL] [Abstract][Full Text] [Related]
8. The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.
Bringmann G; God R; Feineis D; Wesemann W; Riederer P; Rausch WD; Reichmann H; Sontag KH
J Neural Transm Suppl; 1995; 46():235-44. PubMed ID: 8821060
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.
Storch A; Hwang YI; Bringmann G; Feineis D; Ott S; Brückner R; Schwarz J
J Neural Transm (Vienna); 2006 Dec; 113(12):1895-901. PubMed ID: 16868795
[TBL] [Abstract][Full Text] [Related]
10. Endogenous alkaloids in man. XXXVIII. "Chiral" and "achiral" determination of the neurotoxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) from blood and urine samples by high-performance liquid chromatography--electrospray ionization tandem mass spectrometry.
Bringmann G; Münchbach M; Feineis D; Messer K; Diem S; Herderich M; Clement HW; Stichel-Gunkel C; Kuhn W
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):321-32. PubMed ID: 11885861
[TBL] [Abstract][Full Text] [Related]
11. [The plasma level of the neurotoxin 1-trichloromethyl-1,2,4,5-tetrahydro-beta-carboline (TaClo) in man after oral administration of chloral hydrate].
Leuschner J; Beuscher N; Zimmermann T; Schürer M; Schulz HU; Jeromin J; Ritter H
Arzneimittelforschung; 1998 Jan; 48(1):1-5. PubMed ID: 9522023
[TBL] [Abstract][Full Text] [Related]
12. Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate.
Bringmann G; God R; Fähr S; Feineis D; Fornadi K; Fornadi F
Anal Biochem; 1999 May; 270(1):167-75. PubMed ID: 10328779
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
